263 results
8-K
EX-99.1
LFCR
Lifecore Biomedical Inc
16 May 24
Lifecore Biomedical Completes Incremental Liquidity Initiatives
4:48pm
, respectively.
Incentive Plan Amendment
On May 1, 2024, the Compensation Committee and the Board approved an amendment to the Company’s 2024 Annual … Incentive Plan as it relates to James G. Hall and John D. Morberg, the Company’s executive officers. Under the terms of the amendment, any cash
8-K
EX-10.1
LFCR
Lifecore Biomedical Inc
14 May 24
Entry into a Material Definitive Agreement
5:04pm
any grant of stock, stock options or other equity based awards (including any long-term management equity incentive 16
plans) and the payment … or supplier’s allowances, credits, discounts, rebates, rebate accruals, or bonus credits, incentive plans or similar arrangements entitling such Borrower
8-K
LFCR
Lifecore Biomedical Inc
7 May 24
Departure of Directors or Certain Officers
4:48pm
-incentive award plan for the Company’s fiscal year 2024 (the “2024 Annual Incentive Plan”), which was recommended by the Compensation Committee of the Board … Incentive Plan as it relates to James G. Hall and John D. Morberg, the Company’s executive officers. Under the amended terms, Messrs. Hall and Morberg
8-K
EX-10.1
LFCR
Lifecore Biomedical Inc
20 Mar 24
Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes
6:32pm
, the Company will make appropriate adjustments to your tax withholdings, reflecting the fact of said repayment.
Annual Cash Incentive: Beginning … with Lifecore’s fiscal year 2025, you will be eligible to participate in Lifecore’s annual incentive plan (“AIP”), which is a cash incentive program based
8-K
LFCR
Lifecore Biomedical Inc
20 Mar 24
Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes
6:32pm
of the Effective Date;
beginning with the Company’s fiscal year 2025, eligibility to participate in the Company’s annual incentive plan and for the 2025 annual … incentive plan, eligibility for a bonus of 100% of his base salary at the target level of achievement;
a restricted stock unit (“RSU”) award
8-K
EX-10.3
knw2y8 fl
20 Mar 24
Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes
6:32pm
8-K
EX-10.2
wyxyuz
20 Mar 24
Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes
6:32pm
424B3
s1m4st9932duuz5be
9 Jun 23
Prospectus supplement
4:31pm
8-K
EX-10.3
mg4e6c
22 May 23
New $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loan
9:57pm
S-8
EX-23.1
jhl54pjrl2ecy
6 Apr 23
Registration of securities for employees
5:12pm
S-8
r3fmjz
6 Apr 23
Registration of securities for employees
5:12pm
S-8
2rufgbmxhn5to4pcy0gl
6 Apr 23
Registration of securities for employees
5:12pm
S-8
EX-5.1
x48yv6uuic
6 Apr 23
Registration of securities for employees
5:12pm